Literature DB >> 19843516

Triadin deletion induces impaired skeletal muscle function.

Sarah Oddoux1, Julie Brocard, Annie Schweitzer, Peter Szentesi, Benoit Giannesini, Jacques Brocard, Julien Fauré, Karine Pernet-Gallay, David Bendahan, Joël Lunardi, Laszlo Csernoch, Isabelle Marty.   

Abstract

Triadin is a multiple proteins family, some isoforms being involved in muscle excitation-contraction coupling, and some having still unknown functions. To obtain clues on triadin functions, we engineered a triadin knock-out mouse line and characterized the physiological effect of triadin ablation on skeletal muscle function. These mice presented a reduced muscle strength, which seemed not to alter their survival and has been characterized in the present work. We first checked in these mice the expression level of the different proteins involved in calcium homeostasis and observed in fast muscles an increase in expression of dihydropyridine receptor, with a large reduction in calsequestrin expression. Electron microscopy analysis of KO muscles morphology demonstrated the presence of triads in abnormal orientation and a reduction in the sarcoplasmic reticulum terminal cisternae volume. Using calcium imaging on cultured myotubes, we observed a reduction in the total amount of calcium stored in the sarcoplasmic reticulum. Physiological studies have been performed to evaluate the influence of triadin deletion on skeletal muscle function. Muscle strength has been measured both on the whole animal model, using hang test or electrical stimulation combined with NMR analysis and strength measurement, or on isolated muscle using electrical stimulation. All the results obtained demonstrate an important reduction in muscle strength, indicating that triadin plays an essential role in skeletal muscle function and in skeletal muscle structure. These results indicate that triadin alteration leads to the development of a myopathy, which could be studied using this new animal model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843516      PMCID: PMC2787354          DOI: 10.1074/jbc.M109.022442

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Cloning and characterization of a new isoform of skeletal muscle triadin.

Authors:  I Marty; D Thevenon; C Scotto; S Groh; S Sainnier; M Robert; D Grunwald; M Villaz
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

2.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

3.  Measurements of ATP binding on the large cytoplasmic loop of the sarcoplasmic reticulum Ca(2+)-ATPase overexpressed in Escherichia coli.

Authors:  M J Moutin; M Cuillel; C Rapin; R Miras; M Anger; A M Lompré; Y Dupont
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

4.  Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle.

Authors:  B E Flucher; C Franzini-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Molecular interaction between ryanodine receptor and glycoprotein triadin involves redox cycling of functionally important hyperreactive sulfhydryls.

Authors:  G Liu; I N Pessah
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

6.  Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins.

Authors:  Pierre Tijskens; Larry R Jones; Clara Franzini-Armstrong
Journal:  J Mol Cell Cardiol       Date:  2003-08       Impact factor: 5.000

7.  Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum.

Authors:  W Guo; K P Campbell
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

8.  Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene.

Authors:  H Takeshima; M Iino; H Takekura; M Nishi; J Kuno; O Minowa; H Takano; T Noda
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

9.  Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Authors:  F Galbiati; J A Engelman; D Volonte; X L Zhang; C Minetti; M Li; H Hou; B Kneitz; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

10.  In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE).

Authors:  V Dupé; M Davenne; J Brocard; P Dollé; M Mark; A Dierich; P Chambon; F M Rijli
Journal:  Development       Date:  1997-01       Impact factor: 6.868

View more
  36 in total

1.  Fluvastatin-induced alterations of skeletal muscle function in hypercholesterolaemic rats.

Authors:  Márta Füzi; Zoltán Palicz; János Vincze; Julianna Cseri; Zita Szombathy; Ilona Kovács; Anna Oláh; Péter Szentesi; Pál Kertai; György Paragh; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2011-11-09       Impact factor: 2.698

2.  On the footsteps of Triadin and its role in skeletal muscle.

Authors:  Claudio F Perez
Journal:  World J Biol Chem       Date:  2011-08-26

3.  Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats.

Authors:  J Vincze; Á Jenes; M Füzi; J Almássy; R Németh; G Szigeti; B Dienes; Z Gaál; P Szentesi; I Jóna; P Kertai; G Paragh; L Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2015-04-29       Impact factor: 2.698

Review 4.  Ryanodine receptor studies using genetically engineered mice.

Authors:  Alexander Kushnir; Matthew J Betzenhauser; Andrew R Marks
Journal:  FEBS Lett       Date:  2010-03-07       Impact factor: 4.124

Review 5.  Excitation-contraction coupling and minor triadic proteins in low-frequency fatigue.

Authors:  Edward M Balog
Journal:  Exerc Sport Sci Rev       Date:  2010-07       Impact factor: 6.230

6.  Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse.

Authors:  Marine Cacheux; Jérémy Fauconnier; Jérôme Thireau; Alexis Osseni; Jacques Brocard; Nathalie Roux-Buisson; Julie Brocard; Julien Fauré; Alain Lacampagne; Isabelle Marty
Journal:  Mol Ther       Date:  2019-09-13       Impact factor: 11.454

7.  Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle.

Authors:  Tamás Oláh; Dóra Bodnár; Adrienn Tóth; János Vincze; János Fodor; Barbara Reischl; Adrienn Kovács; Olga Ruzsnavszky; Beatrix Dienes; Péter Szentesi; Oliver Friedrich; László Csernoch
Journal:  J Physiol       Date:  2016-10-27       Impact factor: 5.182

8.  Reduced gain of excitation-contraction coupling in triadin-null myotubes is mediated by the disruption of FKBP12/RyR1 interaction.

Authors:  Jose M Eltit; John Szpyt; Hongli Li; Paul D Allen; Claudio F Perez
Journal:  Cell Calcium       Date:  2011-02       Impact factor: 6.817

9.  Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification.

Authors:  Stéphane Vassilopoulos; Sarah Oddoux; Séverine Groh; Marine Cacheux; Julien Fauré; Julie Brocard; Kevin P Campbell; Isabelle Marty
Journal:  Biochemistry       Date:  2010-07-27       Impact factor: 3.162

Review 10.  Triadin regulation of the ryanodine receptor complex.

Authors:  Isabelle Marty
Journal:  J Physiol       Date:  2014-10-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.